AKT1 and neoplasm: Mechanistically, PI3KCA activation converges on AKT–mTOR signaling while sculpting the immune-metabolic milieu, favoring increased Treg recruitment and impaired CD8+ effector function, features characteristic of the tolerogenic tumor microenvironment of glioblastoma [68,69,70].